Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Leander

Showing results (131-140 of 155) with videos related to

Pageof 16
Sort By:
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|August 1, 1992
Subchronic toxicity, metabolism, and pharmacokinetics of the aminobenzamide anticonvulsant ameltolide (LY201116) in rhesus monkeysJ A Engelhardt, C J Parli, P M Kovach, et al.
Journal of Medicinal Chemistry|July 22, 1994
Discovery of a potent, peripherally selective trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonist for the treatment of gastrointestinal motility disordersD M Zimmerman, J S Gidda, B E Cantrell, et al.
Journal of Medicinal Chemistry|September 1, 1986
Structure-activity relationships of (arylalkyl)imidazole anticonvulsants: comparison of the (fluorenylalkyl)imidazoles with nafimidone and denzimolD W Robertson, J H Krushinski, E E Beedle, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1988
Metabolism of the prodrug DEGA (N-(2,6-dimethylphenyl)-4-[[(diethylamino)acetyl]amino]benzamide) to the potent anticonvulsant LY201116 in mice. Effect of bis-(p-nitrophenyl)phosphateC J Parli, E Evenson, B D Potts, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1976
Oral ingestion of narcotic analgesics by ratsD E McMillan, J D Leander, T W Wilson, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1990
Pharmacological characterization of LY233053: a structurally novel tetrazole-substituted competitive N-methyl-D-aspartic acid antagonist with a short duration of actionD D Schoepp, P L Ornstein, J D Leander, et al.
Journal of Medicinal Chemistry|January 1, 1991
4-(Tetrazolylalkyl)piperidine-2-carboxylic acids. Potent and selective N-methyl-D-aspartic acid receptor antagonists with a short duration of actionP L Ornstein, D D Schoepp, M B Arnold, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Heteroatom-substitution as a strategy for increasing the potency of competitive NMDA antagonistsP L Ornstein, M B Arnold, W H Lunn, et al.
European Journal of Pharmacology|October 15, 1991
D,L-(tetrazol-5-yl) glycine: a novel and highly potent NMDA receptor agonistD D Schoepp, C L Smith, D Lodge, et al.
Journal of Medicinal Chemistry|October 1, 1987
Discovery and anticonvulsant activity of the potent metabolic inhibitor 4-amino-N-(2,6-dimethylphenyl)-3,5-dimethylbenzamideD W Robertson, J D Leander, R Lawson, et al.
Pageof 16

Showing results (131-140 of 155) with videos related to

Sort By:
Pageof 16
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|August 1, 1992
Subchronic toxicity, metabolism, and pharmacokinetics of the aminobenzamide anticonvulsant ameltolide (LY201116) in rhesus monkeysJ A Engelhardt, C J Parli, P M Kovach, et al.
Journal of Medicinal Chemistry|July 22, 1994
Discovery of a potent, peripherally selective trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonist for the treatment of gastrointestinal motility disordersD M Zimmerman, J S Gidda, B E Cantrell, et al.
Journal of Medicinal Chemistry|September 1, 1986
Structure-activity relationships of (arylalkyl)imidazole anticonvulsants: comparison of the (fluorenylalkyl)imidazoles with nafimidone and denzimolD W Robertson, J H Krushinski, E E Beedle, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1988
Metabolism of the prodrug DEGA (N-(2,6-dimethylphenyl)-4-[[(diethylamino)acetyl]amino]benzamide) to the potent anticonvulsant LY201116 in mice. Effect of bis-(p-nitrophenyl)phosphateC J Parli, E Evenson, B D Potts, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1976
Oral ingestion of narcotic analgesics by ratsD E McMillan, J D Leander, T W Wilson, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1990
Pharmacological characterization of LY233053: a structurally novel tetrazole-substituted competitive N-methyl-D-aspartic acid antagonist with a short duration of actionD D Schoepp, P L Ornstein, J D Leander, et al.
Journal of Medicinal Chemistry|January 1, 1991
4-(Tetrazolylalkyl)piperidine-2-carboxylic acids. Potent and selective N-methyl-D-aspartic acid receptor antagonists with a short duration of actionP L Ornstein, D D Schoepp, M B Arnold, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Heteroatom-substitution as a strategy for increasing the potency of competitive NMDA antagonistsP L Ornstein, M B Arnold, W H Lunn, et al.
European Journal of Pharmacology|October 15, 1991
D,L-(tetrazol-5-yl) glycine: a novel and highly potent NMDA receptor agonistD D Schoepp, C L Smith, D Lodge, et al.
Journal of Medicinal Chemistry|October 1, 1987
Discovery and anticonvulsant activity of the potent metabolic inhibitor 4-amino-N-(2,6-dimethylphenyl)-3,5-dimethylbenzamideD W Robertson, J D Leander, R Lawson, et al.
Pageof 16